Moderator: ofonorow
Statins Given for 5 Years for Heart Disease Prevention (With Known Heart Disease)
83 for mortality
In Summary, for those who took the statin for 5 years:
Benefits in NNT
1 in 83 were helped (life saved)
1 in 39 were helped (preventing non-fatal heart attack)
1 in 125 were helped (preventing stroke)
Harms in NNH
1 in 100 were harmed (develop diabetes*)
1 in 10 were harmed (muscle damage)
*The development of diabetes is one such unanticipated harm found in a recent large study and it seems likely therefore that this applies to the data above, although this is a best guess.
Aspirin to Prevent Cardiovascular Disease in Patients with Known Heart Disease or Strokes
333 for mortality
In Summary, for those who took the aspirin:
Benefits in NNT
1 in 50 were helped (cardiovascular problem prevented)
1 in 333 were helped (prevented death)
1 in 77 were helped (prevented non-fatal heart attack)
1 in 200 were helped (prevented non-fatal stroke)
Harms in NNH
1 in 400 were harmed (major bleeding event*)
*Required hospital admission and transfusion
Blood Pressure Medicines for Five Years to Prevent Death, Heart Attacks, and Strokes
125 for mortality
In Summary, for those who took anti-hypertensives:
Benefits in NNT
1 in 125 were helped (prevented death)
1 in 67 were helped (prevented stroke)
1 in 100 were helped (prevented heart attack*)
Harms in NNH
1 in 10 were harmed (medication side effects, stopping the drug)
*fatal and non-fatal myocardial infarction and sudden or rapid cardiac death
Clopidogrel Added to Aspirin to Prevent a Second Heart Attack Or Stroke
None for mortality
In Summary, for those who took the clopidogrel:
Benefits in NNT
None were helped (cardiovascular problem prevented)
Harms in NNT
1 in 167 were harmed (major bleeding event*)
Coronary Stenting for Non-Acute Coronary Disease Compared to Medical Therapy
None for mortality
In Summary, for those who received the stenting:
Benefits in NNT
None were helped (life saved, heart attack prevented, symptoms reduced)
Harms in NNH
1 in 50 were harmed (complications such as bleeding, stroke, kidney damage)
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndrome and Stable Coronary Artery Disease
None for mortality
In summary, for patients who received ticagrelor:
Benefits in NNT
No patients were helped
Harms in NNT
1 in 166 patients had a major bleeding event
1 in 13 patients developed dyspnea
Return to “Heart Disease: Linus Pauling's Vitamin C/Lysine Therapy”
Users browsing this forum: Ahrefs [Bot], Semrush [Bot] and 17 guests